Talphera TLPH
NASDAQ TLPH
$1.24 +0.01 (+1.23%)
As of: Sep 10, 2026 · 1:39 PM EDT

Talphera (TLPH) Income from Discontinued Operations (2022 - 2025)

Talphera (TLPH) posted Income from Discontinued Operations of $73000.0 for Q1 2025, up 708.33% on a QoQ basis from -$12000.0 in Q4 2023.

Analysis

Talphera (TLPH) Income from Discontinued Operations (2022 - 2025) Analysis & Trends

Talphera has reported Income from Discontinued Operations for 3 years, with the latest figure at $73000.0 in Q1 2025.

  • On a quarterly basis, Income from Discontinued Operations changed N/A year-over-year to $73000.0 in Q1 2025; TTM through Dec 2025 was $73000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $73000.0, changed N/A from the prior year.
  • Income from Discontinued Operations was $73000.0 for Q1 2025 at Talphera, up from -$12000.0 in the prior quarter.
  • The five-year high for Income from Discontinued Operations was $8.2 million in Q1 2023, with the low at -$4.1 million in Q1 2022.
  • Average Income from Discontinued Operations over 3 years is -$330555.6, with a median of -$12000.0 recorded in 2023.
  • The largest YoY upside for Income from Discontinued Operations was 302.41% in 2023 against a maximum downside of 99.22% in 2023.
  • Over 3 years, Income from Discontinued Operations stood at -$1.5 million in 2022, then surged by 99.22% to -$12000.0 in 2023, then surged by 708.33% to $73000.0 in 2025.
  • The last three Income from Discontinued Operations figures came in at $73000.0 (Q1 2025), -$12000.0 (Q4 2023), and $61000.0 (Q3 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Amgen 206.67 Bn 192.69 Bn 7.24 Bn -
2 Gilead Sciences 180.06 Bn 176.88 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 131.44 Bn 123.59 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.94 Bn 73.95 Bn 3.93 Bn -
5 Argenx Se 60.28 Bn 55.10 Bn 1.37 Bn -
6 Moderna 53.87 Bn 48.73 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.15 Bn 29.85 Bn 992.69 Mn -
8 Biogen 31.88 Bn 30.60 Bn 1.96 Bn -
9 Roivant Sciences 29.16 Bn 29.16 Bn 1.16 Mn -
10 Talphera 93.28 Mn 93.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 73,000.00
Dec 31, 2023 -12,000.00
Sep 30, 2023 61,000.00
Jun 30, 2023 57,000.00
Mar 31, 2023 8.22 Mn
Dec 31, 2022 -1.55 Mn
Sep 30, 2022 -2.11 Mn
Jun 30, 2022 -3.65 Mn
Mar 31, 2022 -4.06 Mn